ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 90 filers reported holding ONCOCYTE CORP in Q1 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,316 | +10.4% | 15,000 | 0.0% | 0.00% | – |
| Q4 2022 | $4,814 | -56.2% | 15,000 | 0.0% | 0.00% | – |
| Q3 2022 | $11,000 | -15.4% | 15,000 | 0.0% | 0.00% | – |
| Q2 2022 | $13,000 | -40.9% | 15,000 | 0.0% | 0.00% | – |
| Q1 2022 | $22,000 | -33.3% | 15,000 | 0.0% | 0.00% | – |
| Q4 2021 | $33,000 | -57.7% | 15,000 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $78,000 | +116.7% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $36,000 | +71.4% | 15,000 | 0.0% | 0.00% | – |
| Q3 2020 | $21,000 | -27.6% | 15,000 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $29,000 | -21.6% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $37,000 | +8.8% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $34,000 | +6.2% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $32,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 14,716,204 | $20,456,000 | 1.61% |
| PURA VIDA INVESTMENTS, LLC | 6,022,534 | $8,371,000 | 0.43% |
| P.A.W. CAPITAL CORP | 199,700 | $278,000 | 0.30% |
| Penbrook Management LLC | 229,425 | $319,000 | 0.28% |
| PERKINS CAPITAL MANAGEMENT INC | 39,725 | $55,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 201,047 | $279,000 | 0.05% |
| Private Wealth Partners, LLC | 150,000 | $209,000 | 0.02% |
| Phoenix Holdings Ltd. | 317,138 | $426,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 255,300 | $355,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 157,933 | $226,000 | 0.01% |